Effects of high doses of recombinant human follicle-stimulating hormone in the treatment of male factor infertility: results of a pilot study

Fertility and Sterility

Volumn 86, Issue 3, 2006, Pages 728-731

  Paradisi, Roberto ^a   Busacchi, Paolo ^a   Seracchioli, Renato ^a   Porcu, Eleonora ^a   Venturoli, Stafano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT FOLLITROPIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FOLLITROPIN BLOOD LEVEL; HUMAN; MALE; MALE INFERTILITY; MORPHOLOGY; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPERMATOZOON MOTILITY;

ADULT; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FOLLICLE STIMULATING HORMONE; HUMANS; INFERTILITY, MALE; MALE; OLIGOSPERMIA; PILOT PROJECTS; PLACEBO EFFECT; RECOMBINANT PROTEINS; SPERM COUNT; SPERM MOTILITY; SPERMATOGENESIS; SPERMATOZOA; TREATMENT OUTCOME;

EID: 33748101911     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.02.087     Document Type: Article

References (29)

1. Nieschlag E., Simoni M., Gromoll J., and Weinbauer G.F. Role of FSH in the regulation of spermatogenesis: clinical aspects. Clin Endocrinol 51 (1999) 139-146
2. Moudgal N.R., and Sairam M.R. Is there a true requirement for follicle stimulating hormone in promoting spermatogenesis and fertility in primates?. Hum Reprod 13 (1998) 916-919
3. Acosta A.A., Oehninger S., Ertunc H., and Philput C. Possible role of pure human follicle-stimulating hormone in the treatment of severe male-factor infertility by assisted reproduction: preliminary report. Fertil Steril 55 (1991) 1150-1156
4. Acosta A.A., Khalifa E., and Oehninger S. Pure human follicle stimulating hormone has a role in the treatment of severe male infertility by assisted reproduction: Norfolk's total experience. Hum Reprod 7 (1992) 1067-1072
5. Matorras R., Perez C., Corcostegui B., Pijoan J.I., Ramon O., Delgado P., et al. Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband's spermatozoa: a randomized study. Hum Reprod 12 (1997) 24-28
6. Ben-Rafael Z., Farhi J., Feldberg D., Bartoov B., Kovo M., Eltes F., et al. Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential. Fertil Steril 73 (2000) 24-30
7. Kamischke A., Behre H.M., Bergmann M., Simoni M., Schafer T., and Nieschlag E. Recombinant human stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod 13 (1998) 596-603
8. Huhtaniemi I. The Parkes lecture. Mutations of gonadotrophin and gonadotrophin receptor genes: what do they teach us about reproductive physiology?. J Reprod Fertil 119 (2000) 173-186
9. Plant T.M., and Marshall G.R. The functional significance of FSH in spermatogenesis and the control of its secretion in male primates. Endocr Rev 22 (2001) 764-786
10. Ashkenazi J., Bar-Hava I., Farhi J., Levy T., Feldberg D., Orvieto R., et al. The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection. Fertil Steril 72 (1999) 670-673
11. Bartoov B., Har-Evn D., Eltes F., Ledermann H., Lunenfeld E., and Lunenfeld B. Sperm quality of subfertile males before and after treatment with human follicle-stimulating hormone. Fertil Steril 61 (1994) 727-734
12. Balaban B., Urman B., Sertac A., Alatas C., Aksoy S., Mercan R., et al. In-vitro culture of spermatozoa induces motility and increases implantation and pregnancy rates after testicular sperm extraction and intracytoplasmic sperm injection. Hum Reprod 14 (1999) 2808-2811
13. Arnaldi G., Balercia G., Barbatelli G., and Mantero F. Effects of long-term treatment with human pure follicle-stimulating hormone on semen parameters and sperm-cell ultrastructure in idiopathic oligoteratoasthenozoospermia. Andrologia 32 (2000) 155-161
14. Foresta C., Bettella A., Merico M., Garolla A., Ferlin A., and Rossato M. Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility. Fertil Steril 77 (2002) 238-244
15. Caroppo E., Niederberger C., Vizziello G.M., and D'Amato G. Recombinant human follicle-stimulating hormone as a pretreatment for idiopathic oligoasthenoteratozoospermic patients undergoing intracytoplasmic sperm injection. Fertil Steril 80 (2003) 1398-1403
16. Saal W., Baum R.P., Happ J., Schmidt M., and Cordes U. Subcutaneous gonadotropin therapy in male patients with hypogonadotropic hygonadism. Fertil Steril 56 (1991) 319-324
17. le Cotonnec J.Y., Porchet H.C., Beltrami V., and Howles C.M. Comparative pharmacokinetics of two urinary human follicle stimulating hormone preparations in healthy female and male volunteers. Hum Reprod 8 (1993) 1604-1611
18. Paradisi R., Mancini R., Bellavia E., Beltrandi E., Pession A., Venturoli S., et al. T-helper type 2 cytokine and solubile interleukin-2 receptor levels in seminal plasma of infertile men. Am J Reprod Immunol 38 (1997) 94-99
19. World Health Organization. Laboratory manual for the examination of human semen and sperm-cervical mucus interaction (1999), Cambridge University Press, Cambridge (UK)
20. Paradisi R., Lodi S., Bolelli G., and Venturoli S. Radioimmunoassay of three oestrogens and three androgens in the same plasma sample after extraction and chromatographic separation. Acta Endocrinol (Copenh) 94 (1980) 229-234
21. Flamigni C., Venturoli S., and Paradisi R. La FSH purifiée dans le syndrome de l'ovaire micropolykystique. Contrac Fertil Sexual (Paris) 13 (1985) 1097-1101
22. Loumaye E., Campbell R., and Salat-Baroux J. Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians. Hum Reprod Update 1 (1995) 188-199
23. Jockenhovel F., Fingscheidt U., Khan S.A., and Behre H.M. Immunoactivity of FSH in serum after intramuscular injection of highly purified urinary human FSH in normal men. Clin Endocrinol 33 (1990) 573-584
24. Foresta C., Bettella A., Merico M., Garolla A., Plebani M., Ferlin A., et al. FSH in the treatment of oligozoospermia. Mol Cell Endocrinol 161 (2000) 89-97
25. Dirnfeld M., Katz G., Calderon I., Abramovici H., and Bider D. Pure follicle-stimulating hormone as an adjuvant therapy for selected cases in male infertility during in-vitro fertilization is beneficial. Eur J Obstet Gynecol Reprod Biol 93 (2000) 105-108
26. Liu P.Y., Turner L., Rushford D., McDonald J., Baker H.W., Conway A.J., et al. Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men. Hum Reprod 14 (1999) 1540-1545
27. Mannaerts B., Shoham Z., Fauser B., Bennink H.C., Lahlou N., Bouchard P., et al. Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism. Fertil Steril 65 (1996) 406-410
28. le Cotonnec J.Y., Porchet H.C., Beltrami V., Khan A., Toon S., and Rowland M. Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). II. Single doses and steady state pharmacokinetics. FSH. Fertil Steril 61 (1994) 679-686
29. Adamopoulos D.A. Present and future therapeutics strategies for idiopathic oligozoospermia. Int J Androl 23 (2000) 320-331